Linked from

The 15 pages that link to Acute myeloid leukemia, each with the reason it gives.

• Hematopoietic stem cell transplantationRelated: Allogeneic transplantation can reduce relapse risk for selected patients with this leukemia.

• Aplastic anemiaCompared with: Leukemia can cause cytopenias, but marrow blasts distinguish it from aplastic anemia.

• LeukemiaBroader topic: It is a major acute leukemia subtype defined by myeloid lineage.

• Minimal residual diseaseBroader topic: Post-treatment MRD can help identify patients at elevated risk of relapse.

• Myelodysplastic syndromeBroader topic: MDS can evolve into AML as abnormal clones accumulate blasts.

• Acute lymphoblastic leukemiaCompared with: It is the main acute leukemia counterpart, arising from a different blood-cell lineage.

• Clonal hematopoiesisCompared with: Clonal hematopoiesis can precede this malignancy, but is not itself leukemia.

• Bone-marrow transplantationRelated: Allogeneic transplantation is considered for some patients at substantial risk of relapse.

• CytarabineRelated: Cytarabine is a backbone drug in induction and consolidation regimens for this leukemia.

• Bloom syndromeBroader topic: It is among the early-onset cancers reported in people with Bloom syndrome.

• Fanconi anemiaRelated: Fanconi anemia substantially increases the risk of this leukemia.

• Myeloid cellBroader topic: It is a direct malignancy of myeloid-lineage precursors.

• Essential thrombocythemiaRelated: Leukemic transformation is rare but represents a serious long-term disease complication.

• DaunorubicinRelated: Daunorubicin is a standard component of induction chemotherapy for many patients with this leukemia.

• Diamond–Blackfan anemiaRelated: This malignancy is among the serious cancers associated with Diamond–Blackfan anemia.